In the current trading session, Cocrystal Pharma Inc’s (COCP) stock is trading at the price of $1.87, a gain of 8.09% over last night’s close. So, the stock is trading at a price that is -42.64% less than its 52-week high of $3.26 and 66.96% better than its 52-week low of $1.12.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, COCP’s SMA-200 is $1.7713.
COCP’s price to book ratio for the most recent quarter was 2.60, resulting in an 2.72 price to cash per share for the period.
How does Cocrystal Pharma Inc (COCP) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Cocrystal Pharma Inc (COCP): Earnings History
If we examine Cocrystal Pharma Inc’s recent earnings history, in the last quarter ended on 3/31/2025, it posted adjusted earnings per share of -$0.23, slashing the consensus of -$0.5. In other words, it beat the consensus by $0.28, resulting in a 54.46% surprise. In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.23 in contrast with the Outlook of -$0.5. That was a difference of $0.28 and a surprise of 54.46%.
Cocrystal Pharma Inc (NASDAQ: COCP) Ownership Details
I will give a breakdown of the key shareholders in Cocrystal Pharma Inc (COCP). Recent figures show that the company’s insiders hold 36.35% of shares. A total of 24 institutional investors hold shares in the company, making 7.36% of its stock and 11.56% of its float.
Mar 31, 2025, it was reported that the Company’s largest institutional holder is Vanguard Group Inc holding total of 275.66 shares that make 2.71% of the company’s total number of shares and are currently priced at 0.52 million.
The securities firm Renaissance Technologies, LLC holds 125.63 shares of COCP, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.23%, and the holding percentage of shares is valued at 0.24 million.
An overview of Cocrystal Pharma Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Cocrystal Pharma Inc (COCP) traded 116,068 shares per day, with a moving average of $1.6624 and price change of +0.3650. With the moving average of $1.5942 and a price change of +0.3700, about 60,003 shares changed hands on average over the past 50 days. Finally, COCP’s 100-day average volume is 38,544 shares, alongside a moving average of $1.5344 and a price change of +0.2650.
